federal_register: 2022-22844
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-22844 | Agency Information Collection Activities: Proposed Collection; Comment Request | Notice | On Wednesday, October 5, 2022, the Centers for Medicare & Medicaid Services (CMS) published a notice document entitled, "Agency Information Collection Activities: Proposed Collection; Comment Request". That notice invited public comments on two separate information collection requests, under Document Identifiers: CMS-10260 and CMS-10142. Through the publication of this document, we are withdrawing the portion of the notice requesting public comment on the information collection request titled, " Medicare Advantage and Prescription Drug Program: Final Marketing Provisions." Form number: CMS-10260 (OMB control number: 0938-1051). | 2022-10-21 | 2022 | 10 | https://www.federalregister.gov/documents/2022/10/21/2022-22844/agency-information-collection-activities-proposed-collection-comment-request | https://www.govinfo.gov/content/pkg/FR-2022-10-21/pdf/2022-22844.pdf | Health and Human Services Department; Centers for Medicare & Medicaid Services | 221,45 | On Wednesday, October 5, 2022, the Centers for Medicare & Medicaid Services (CMS) published a notice document entitled, "Agency Information Collection Activities: Proposed Collection; Comment Request". That notice invited public comments on two... |